Phaseline

Targets › PTGS2

PTGS2 (Prostaglandin G/H synthase 2): drug programs, companies and trials

66 programs from 60 companies in 162 trials: 72 Phase 2, 38 Phase 4, 28 Phase 1, 24 Phase 3; Other, Oncology, Immunology; next expected readout Dec 2026.

Dual cyclooxygenase and peroxidase in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response. The cyclooxygenase activity oxygenates AA to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the peroxidase activity reduces PGG2 to the hydroxy endoperoxide…. (UniProt, P35354)

Open in Phaseline: the race on PTGS2, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
The University of Texas Health Science Center, HoustonALA 10% gel
Muscle-type nicotinic acetylcholine receptor antagonist
HCRTR2, HCRTR1, CHRNA1, CHRNG, CHRNB1, CHRND, CHRNE, HTR2A, PTGS2, PTGS1Phase 4Anesthesia; Cleft Lip and Palate; Pancreatic Ductal Adenocarcinoma (PDAC); Stimulant Use Disorder …Dec 2026
Changhai HospitalIndomethacin
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Post-ERCP PancreatitisDec 2026
University of CalgaryCBD 100 mg OD
Interleukin-23 inhibitor
CNR1, PLAT, IL12B, IL23A, ADRB2, HTR2A, NR3C1, TNF, PTGS2, PTGS1Phase 4Copd; Ehlers-Danlos Syndrome; Crohn Disease; Vasovagal Syncope …Dec 2026
Henry Ford Health SystemKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Femoracetabular Impingement; Narcotic UseDec 2026
Beijing Friendship HospitalFlurbiprofen
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Opioid-free AnesthesiaDec 2026
Massachusetts General HospitalKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Orthopaedic TraumaDec 2026
The University of Hong KongKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Patella FractureDec 2026
Xiangya Hospital of Central South UniversityAcetaminophen-Mannitol Injection
Non-selective COX inhibitor (analgesic) with osmotic agent
PTGS1, PTGS2Phase 4Postoperative DeliriumJan 2027
University of ChicagoKetorolac Tromethamine
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Surgery, Upper ExtremityFeb 2027
University of Maryland St. Joseph Medical CenterKetorolac Tromethamine
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Lumbar Spinal FusionJun 2027
Northwestern UniversityNaproxen
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Osteoarthritis, Knee; Opioid UseJun 2027
Emory UniversityKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4OsteoarthritisJul 2027
Jessica D. KresowikKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Infertility (IVF Patients)Oct 2027
Phoenix Children's Hospitalketorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Congenital Heart Disease in ChildrenOct 2027
Thomas Jefferson UniversityKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Cesarean DeliveryDec 2027
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)bupivacaine-meloxicam (extended release)
Local anesthetic (bupivacaine) combined with NSAID/COX inhibitor (meloxicam)
PTGS1, PTGS2Phase 4Periarticular BlockJan 2028
Peking Union Medical College HospitalIndomethacin
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Acute PancreatitisJun 2028
Long JiangParecoxib
Cyclooxygenase-2 inhibitor
PTGS2Phase 4Lung NodulesJun 2028
University of Colorado, Denverketorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Chronic Kidney DiseaseJun 2028
Endeavor HealthNaproxen Sodium
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4DysmenorrheaApr 2030
Madigan Army Medical CenterKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Low Back Pain–
University of OklahomaMeloxicam
Cyclooxygenase-2 inhibitor
PTGS2Phase 4Postoperative Pain, Acute–
Instituto de Oftalmología Fundación Conde de ValencianaNepafenac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 4Epiphora–
University of AlbertaKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Pain ManagementDec 2026
Laboratorios Silanes S.A. de C.V.Etoricoxib
Cyclooxygenase-2 inhibitor
PTGS2Phase 3Gout Arthritis; Parkinson Disease; Orthodontic Pain (D013850)Dec 2026
St. Louis UniversityKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Bone MetastasesDec 2026
AFT PharmaceuticalsCombogesic® IV
Fixed-dose combination of acetaminophen and ibuprofen
PTGS1, PTGS2Phase 3Acute PainMar 2027
Centre Hospitalier Universitaire, AmiensKetoprofen (RP19583)
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Acute Postoperative Pain; Non-steroidal Anti-inflammatory DrugsMar 2027
NICHD Neonatal Research Networkindomethacin
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Infant, PrematureMay 2027
Brainfarma Industria Química e Farmacêutica S/ADipyrone
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Common Cold/Flu; Hematologic TestJun 2027
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Aortic DissectionSep 2027
The University of Hong KongPiroxicam
Non-selective COX inhibitor
PTGS1, PTGS2Phase 3ContraceptionSep 2027
SWOG Cancer Research Networksulindac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Colorectal NeoplasmsSep 2027
Chinese University of Hong KongIndomethacin
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Post ERCP PancreatitisMay 2028
Université de SherbrookeCBD Oral Solution
FK506-binding protein 1A inhibitor
FKBP1A, PTGS2, IL4RPhase 3Asthma Control; Organ Transplant Failure or Rejection; Fragile X Syndrome; Triple-Negative Breast CancerJul 2028
University of CalgaryKetorolac Tromethamine
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Acute PainJan 2029
Weill Medical College of Cornell UniversityKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 3Mechanical VentilationJul 2029
Laboratorios Silanes S.A. de C.V.Celecoxib
Cyclooxygenase-2 inhibitor
PTGS2Phase 3Joint Pain; Shoulder Arthropathy; Pain, Postoperative; Surgery …–
University of MiamiKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Kidney CancerDec 2026
Emory UniversityDiclofenac Potassium
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Advanced Lung Non-Small Cell CarcinomaJan 2027
St. Anne's University Hospital Brno, Czech RepublicParecoxib
Cyclooxygenase-2 inhibitor
PTGS2Phase 2Neurological ComplicationJan 2027
Massachusetts General HospitalOmega 3 (EPA-enriched)
Pro-resolving lipid mediator precursor; substrate for production of specialized pro-resolv
PTGS1, PTGS2, ALOX5Phase 2Treatment Resistant DepressionMar 2027
Jules Bordet InstituteKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Early-stage Breast CancerApr 2027
Rush University Medical CenterKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Pain ManagementApr 2027
The Cleveland ClinicKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2ACL - Anterior Cruciate Ligament RuptureJun 2027
SirnaomicsSTP705
siRNA targeting TGF-β1 and COX-2 for inflammation and adipose tissue remodeling inhibition
TGFB1, PTGS2Phase 2Submental FullnessJul 2027
AHS Cancer Control AlbertaMesalamine
Arachidonate 5-lipoxygenase inhibitor; Peroxisome proliferator-activated receptor gamma agonist; Cyclooxygenase inhibitor
ALOX5, PPARG, PTGS2, PTGS1Phase 2Immune-related Adverse EventAug 2027
NYU Langone HealthSulfasalazine
Arachidonate 5-lipoxygenase inhibitor; Cyclooxygenase inhibitor
ALOX5, PTGS2, PTGS1Phase 2Rheumatic DiseaseJan 2028
Rutgers, The State University of New JerseySulfasalazine
Arachidonate 5-lipoxygenase inhibitor; Cyclooxygenase inhibitor
ALOX5, PTGS2, PTGS1Phase 2Preterm BirthJan 2028
M.D. Anderson Cancer CenterKetoprofen
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Fibrosis SyndromeJul 2030
Ann-Sofie BackmanMesalamine
Arachidonate 5-lipoxygenase inhibitor; Peroxisome proliferator-activated receptor gamma agonist; Cyclooxygenase inhibitor
ALOX5, PPARG, PTGS2, PTGS1Phase 2Lynch SyndromeSep 2032
British University In EgyptDiclofenac Sodium
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Endodontic Disease–
North American Consortium for HistiocytosisINDOMETHACIN
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2Langerhans Cell Histiocytosis–
Duke UniversitySulindac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 2IPMN–
University of ZurichSulfasalazine
Arachidonate 5-lipoxygenase inhibitor; Cyclooxygenase inhibitor
ALOX5, PTGS2, PTGS1Phase 1GlioblastomaDec 2026
Assistance Publique - Hôpitaux de ParisSulfasalazine
Arachidonate 5-lipoxygenase inhibitor; Cyclooxygenase inhibitor
ALOX5, PTGS2, PTGS1Phase 1Acute Myeloid LeukemiaDec 2026
University of Texas Southwestern Medical CenterKetorolac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1Post Operative PainApr 2027
Caribou BiosciencesLornoxicam (CB-011)
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1Relapsed/Refractory Multiple MyelomaDec 2027
Sana BiotechnologyLornoxicam (SC291)
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1Lupus Erythematosus; Non Hodgkin's Lymphoma; Non Hodgkin Lymphoma; Preterm Premature Rupture of Membrane …Dec 2027
National Institute of Mental Health (NIMH)[11C]MC1
Radioligand for cyclooxygenase-2 (COX-2) imaging
PTGS2, PTGS1Phase 1Parkinson's Disease; DepressionApr 2029
Satish R. RajIndomethacin
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1TachycardiaDec 2029
Rockefeller UniversityNaproxen Sodium
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1Fanconi AnemiaOct 2030
Haiphong University of Medicine and PharmacyDW-1021
Fixed-dose combination of nonsteroidal anti-inflammatory drug and opioid analgesic
PTGS1, PTGS2, OPRM1Phase 1Healthy Volunteer–
ZetrOZDiclofenac
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1Bone Fracture; Osteoarthritis; Blood Gas Analysis; Elbow Pain–
Haiphong University of Medicine and PharmacyPelubiprofen
Non-selective cyclooxygenase (COX) inhibitor
PTGS1, PTGS2Phase 1Healthy Volunteers–
New Valley Universityketoprofen
Cyclooxygenase inhibitor
PTGS2, PTGS1Phase 1Knee Osteoarthritis–

Conditions

Colorectal Cancer (4) Pain Management (2) Osteoarthritis (2) Acute Pain (2) Postoperative Pain, Acute (2) Metastatic Colorectal Cancer (2) Parkinson Disease (2) Orthodontic Pain (D013850) (2) Musculoskeletal Injury (2) Microscopic Colitis (2) Investigating the Importance of the Subjective Psychedelic Experience (2) Knee Osteoarthritis (2)

Modalities

small molecule (55), mixed (7), protein or peptide (2)

Companies

University of Calgary (2) Haiphong University of Medicine and Pharmacy (2) Laboratorios Silanes S.A. de C.V. (2) Massachusetts General Hospital (2) Emory University (2) The University of Hong Kong (2) Rush University Medical Center (1) University of Miami (1) ZetrOZ (1) Centre Hospitalier Universitaire, Amiens (1) SWOG Cancer Research Network (1) Sirnaomics (1) University of Zurich (1) National Institute of Mental Health (NIMH) (1) Instituto de Oftalmología Fundación Conde de Valenciana (1) University of Texas Southwestern Medical Center (1) Caribou Biosciences (1) Université de Sherbrooke (1) University of Oklahoma (1) Sana Biotechnology (1)

Related targets

PTGS1 (59) ALOX5 (7) HTR2A (2) PPARG (2) TGFB1 (1) FKBP1A (1) IL4R (1) OPRM1 (1) CNR1 (1) PLAT (1) IL12B (1) IL23A (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.